0001209191-15-040446.txt : 20150508
0001209191-15-040446.hdr.sgml : 20150508
20150508150130
ACCESSION NUMBER: 0001209191-15-040446
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150506
FILED AS OF DATE: 20150508
DATE AS OF CHANGE: 20150508
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: aTYR PHARMA INC
CENTRAL INDEX KEY: 0001339970
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 203435077
STATE OF INCORPORATION: DE
BUSINESS ADDRESS:
STREET 1: 3545 JOHN HOPKINS COURT, STE #250
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 858-731-8389
MAIL ADDRESS:
STREET 1: 3545 JOHN HOPKINS COURT, STE #250
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Cubitt Andrew
CENTRAL INDEX KEY: 0001641212
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37378
FILM NUMBER: 15846157
MAIL ADDRESS:
STREET 1: C/O ATYR PHARMA, INC.
STREET 2: 3545 JON HOPKINS COURT, SUITE 250
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2015-05-06
0
0001339970
aTYR PHARMA INC
LIFE
0001641212
Cubitt Andrew
C/O ATYR PHARMA, INC.
3545 JOHN HOPKINS COURT, SUITE #250
SAN DIEGO
CA
92121
0
1
0
0
See Remarks
Stock Option (right to buy)
14.00
2015-05-06
4
A
0
5657
A
2025-05-06
Common Stock
5657
5657
D
The shares subject to this option shall vest and become exercisable in 48 equal monthly installments beginning on May 6, 2015, such that this option is fully exercisable on May 6, 2019. This option is subject to accelerated vesting upon termination without cause upon a change of control of the Issuer.
Not applicable.
Vice President, Product Protection
/s/ Nancy Krueger, as Attorney-in-Fact
2015-05-08